Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q3 2019 · 10-Q
Revenue$12.60M$12.60M−7.3% vs Q3 2018 Net Income-$1.77M-$1.77MN/M vs Q3 2018 EPS Diluted-$0.02-$0.02N/M vs Q3 2018 Gross Profit$8,428,000−15.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,058,000N/M Free Cash Flowderived-$1,455,000N/M Margins · derivedGross margin66.9%−6.3 pt vs Q3 2018
Operating margin-14.1%−40.0 pt vs Q3 2018
Net margin-14.0%−38.3 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 6, 2019 · 37 d after period end